Patent US4501734A successfully refreshed from Google Patents.
US4501734A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Promotion of absorption of drugs administered through the alimentary system
Assignee: Wakunaga Pharmaceutical Co Ltd
•
Filing: 1982-03-03
•
Granted: 1985-02-26
•
Expires: 2002-03-03
Abstract
Abstract An extract from a saponin-containing galenical has the effect of promoting absorption of a pharmacologically active substance or drug such as β-lactam antibiotic administered through the alimentary system. In particular, saponin components are isolated from the extract of Sapindus mukurossi Gaertn. and recognized to have similar promotion effect of drug absorption. Thus, it has been made possible to increase absorption of a drug and hence its pharmacological effect by administering these substances in combination with a pharmacologically active substance orally or into the rectum.
Inventors
- 👤 Osamu Tanaka
- 👤 Noboru Yata
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 09:13
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20; C07H15/24; C07H15/256; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/425; A61K31/429; A61K31/43; A61K31/54; A61K31/542; A61K31/545; A61K31/70; A61K47/00; A61K47/06; A61K47/26
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
181 words
A method for enhancing the absorption by an animal of a β-lactam type antibiotic selected from the group consisting of penicillins and cephalosporins, which comprises orally or rectally administering to an animal in need of said antibiotic the antibiotic and a safe and effective amount of a saponin obtained from a plant selected from the group consisting of: (a) Akebia quinata decne. or plants belonging to the same family (Lardizabalaceae); (b) Fatsia japonica Decne. et Pianch; (c) Caulophyllum robustum Maxim.; (d) Hedera rhombea Bean; (e) Clematis chinensis Osbeck; (f) Pulsatilla cernua Spreng; (g) Sapindus mukurossi Gaertn.; (h) Panax japonicum C. A. Meyer; (i) Glycyrrhiza glabra L.var. glandulifera Regel et Herber, Glycyrrhiza uralensis Fisher or plants belonging to the same family (Leguminosae); (j) Polygala senega L. or Polygala senega L. var. Latifolia Torrey et Gray; (k) Platycodon grandiflorum A.D.C.; (l) Polygala tenuifolia Willd.; (m) Achyranthes fauriei Lev. et Van or Achyranthes bidentata Blume; (n) Cyclamen europaenum; (o) Primula officinalis; (p) Bupleurum falcatum L. or its varieties (Umbelliferae); (q) Panax ginseng C. A. Meyer; (r) Panax notoginseng Burkill; and (s) Panax quinquefolium L.
Claim 2
Independent Claim
181 words
A method for enhancing the absorption by an animal of a β-lactam type antibiotic selected from the group consisting of penicillins and cephalosporins, which comprises orally or rectally administering to an animal in need of said antibiotic the antibiotic and a safe and effective amount of a saponin obtained from a plant selected from the group consisting of: (a) Akebia quinata decne. or plants belonging to the same family (Lardizabalaceae); (b) Fatsia japonica Decne. et Pianch; (c) Caulophyllum robustum Maxim.; (d) Hedera rhombea Bean; (e) Clematis chinensis Osbeck; (f) Pulsatilla cernua Spreng; (g) Sapindus mukurossi Gaertn.; (h) Panax japonicum C. A. Meyer; (i) Glycyrrhiza glabra L.var. glandulifera Regel et Herber, Glycyrrhiza uralensis Fisher or plants belonging to the same family (Leguminosae); (j) Polygala senega L. or Polygala senega L. var. Latifolia Torrey et Gray; (k) Platycodon grandiflorum A.D.C.; (l) Polygala tenuifolia Willd.; (m) Achyranthes fauriei Lev. et Van or Achyranthes bidentata Blume; (n) Cyclamen europaenum; (o) Primula officinalis; (p) Bupleurum falcatum L. or its varieties (Umbelliferae); (q) Panax ginseng C. A. Meyer; (r) Panax notoginseng Burkill; and (s) Panax quinquefolium L.
Claim 3
Dependent Claim
25 words
A method according to claim 1 wherein the saponin is administered in a dosage of 2.5 to 250 mg per dose for a human adult.
Claim 4
Dependent Claim
15 words
The method according to claim 1 wherein the saponin is obtained from Sapindus mukurossi Gaertn.
Claim 5
Dependent Claim
17 words
The method according to claim 1 wherein the saponin is obtained from Bupleurum falcatum L. or Umbelliferae.
Claim 6
Dependent Claim
21 words
The method according to claim 1 wherein the saponin is a triterpenoid saponin of the formula ##STR6## wherein R is ##STR7##
Claim 7
Dependent Claim
27 words
The method of claim 1 wherein the antibiotic is ampicillin and the saponin is selected from the group consisting of: (a) 3-O-[α-L-arabinopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1.fwdarw.2)-α-L-arabinopyranosyl]-hederagenin; (b) 3-O-[β-D-xylopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1.fwdarw.2)-α-L-arabinopyranosyl]-hederagenin; and (c) 3-O-[α-L-arabinofuranosyl-(1→3)-α-L-rhamnopyranosyl-(1.fwdarw.2)-α-L-arabinopyranosyl]-hederagenin.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-02-26 | 1988-08-27 | 1989-02-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-02-26 | 1992-08-27 | 1993-02-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-02-26 | 1996-08-27 | 1997-02-26 | $7700.00 | Window Closed / Lapsed |